You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Y90-RE

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Cancer Trial in Manchester (Y90-PET-CT scan)

Recruiting
  • Cancer
  • Y90-PET-CT scan
  • Manchester, United Kingdom
    The Christie NHS - Nuclear Medicine Department
Nov 7, 2023

Locally Advanced Hepatocellular Carcinoma Trial in Singapore (SIRT-Y90 with Atezolizumab + Bevacizumab, SIRT-Y90 with Placebo

Recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • SIRT-Y90 with Atezolizumab + Bevacizumab
  • SIRT-Y90 with Placebo (IV)
  • Singapore, Singapore
  • +1 more
Jan 26, 2023

Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy (PRRT) Trial in Ferrara (Lutetium-177 (177Lu)-DOTATOC, Yttrium-90

Recruiting
  • Neuroendocrine Tumors
  • Peptide Receptor Radionuclide Therapy (PRRT)
  • Lutetium-177 (177Lu)-DOTATOC
  • +4 more
  • Ferrara, Italy
    University Hospital of Ferrara
Mar 5, 2021

HepatoCellular Carcinoma Trial in Singapore (Y-90 Radioembolization, Nivolumab)

Active, not recruiting
  • HepatoCellular Carcinoma
  • Singapore, Singapore
    National Cancer Centre - Singapore
May 25, 2022

Hepatocellular Carcinoma Trial in United States (Y-90 TARE, Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Y-90 TARE
  • +2 more
  • Washington, District of Columbia
  • +5 more
Jan 18, 2023

CNS Lymphoma Trial in Essen ([90Y]Y-PentixaTher)

Recruiting
  • CNS Lymphoma
  • Essen, Germany
    University Hospital Essen
Nov 16, 2023

Liver Cancer Trial in Houston (device, diagnostic test, procedure)

Not yet recruiting
  • Liver Cancer
  • TriSalus™ TriNav™Infusion System
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Feb 23, 2023

HCC, Cancer of Liver, Cancer Trial in Atlanta (SIR-Spheres microspheres)

Completed
  • HCC
  • +2 more
  • SIR-Spheres microspheres
  • Atlanta, Georgia
  • +2 more
Dec 22, 2021

Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Therasphere 90Y
  • Microwave Ablation
  • (no location specified)
Jul 12, 2023

Hepatic Malignancies Trial in Cleveland (PET/CT, PET/MR, SIRT with Y-90)

Completed
Has Results
  • Hepatic Malignancies
  • PET/CT
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jun 1, 2022

Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))

Not yet recruiting
  • Colorectal Neoplasms
  • Resin microspheres containing yttrium-90 (Y-90)
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023

Primary Malignant Liver Tumor Trial in Palo Alto (procedure, device, diagnostic test)

Completed
Has Results
  • Primary Malignant Liver Neoplasm
  • Computed Tomography (CT)
  • +4 more
  • Palo Alto, California
    Stanford University
Dec 8, 2021

Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

Recruiting
  • Pancreatic Neuroendocrine Tumor
  • peptide receptor radionuclide therapy with Y-90-DOTATOC
  • Milano, Italy
  • +1 more
Sep 30, 2022

Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • 90Y-DOTA tyr3-Octreotide
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 6, 2022

Cancer, Dyspnea, Functionality Trial in Salamanca (FUNCTIONAL REEDUCATION AND ENVIRONMENTAL ADAPTATION PROGRAMME, Health

Recruiting
  • Cancer
  • +4 more
  • FUNCTIONAL REEDUCATION AND ENVIRONMENTAL ADAPTATION PROGRAMME
  • Health education programme:
  • Salamanca, Castilla Y Leon, Spain
    Eduardo Jose Fernandez Rodriguez
Sep 11, 2023

Intrahepatic Cholangiocarcinoma Trial in Charleston (SIR-Spheres microspheres (Yttrium-90 Microspheres), Gemcitabine, Cisplatin)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • SIR-Spheres microspheres (Yttrium-90 Microspheres)
  • +2 more
  • Charleston, South Carolina
    Medical University of South Carolina
Nov 11, 2021

Optimizing Y90 Therapy for Radiation Lobectomy

Recruiting
  • HCC
  • +4 more
  • Y90 radioembolization
  • Chicago, Illinois
    Northwestern University
Aug 27, 2021

Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Not yet recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +4 more
  • Angiography
  • +8 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 22, 2023

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

Recruiting
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumors
  • Capecitabine Oral Product
  • +2 more
  • Little Rock, Arkansas
  • +2 more
Aug 11, 2022

Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres

Recruiting
  • Hepatocellular Carcinoma
  • SIRT with Y-90 resin microspheres
  • Dallas, Texas
    Methodist Dallas Medical Center
Nov 9, 2021

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

Not yet recruiting
  • Bile Duct Cancer
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 23, 2023

Ovarian Cancer Trial in New York (90Y-hu3S193, 111In-hu3S193)

Completed
Has Results
  • Ovarian Cancer
  • 90Y-hu3S193
  • 111In-hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022